ENSC
ENSC
NASDAQ · Biotechnology

Ensysce Biosciences Inc

$0.54
+0.02 (+4.77%)
As of Mar 31, 10:16 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +6,954.8% upside
Low Target $25.94
Average Target $37.99
High Target $62.46
Current Price $0.54
Current
$0.54
Target
$37.99
$25.94 $37.99 avg $62.46
Scenario Analysis
Bear Case
$25.94
4,717.1%
Low target
Base Case
$37.99
+6,954.8%
Avg target
Bull Case
$62.46
+11,498.9%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$4.85
-88.9% from high
52-Week Low
$0.31
+71.3% from low
Target vs 52W High
$37.99
+683.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%